Covidien's HawkOne Directional Atherectomy System Receives FDA 510(K) Clearance For The Treatment Of Peripheral Arterial Disease
November 04, 2014 at 07:05 AM EST
Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy ...
